Recent Updates Toggle Comment Threads | Keyboard Shortcuts

  • ShereeKrider 11:50 pm on June 14, 2017 Permalink | Reply
    Tags: AG Andy Beshear, Amy Stalker, Attorney Candace Curtis, Attorney Dan Canon, Bath County, , Dan Seum Jr., Danny Belcher, doctor patient relationship, Frankfort, Gov. Matt Bevin, , Jefferson County, , Kentucky Constitution, , , , , right to privacy, WLKY   

    (KY) GOV. MATT BEVIN AND AG ANDY BESHEAR GET SUED OVER MEDICAL MARIJUANA! 


    BECAUSE THIS STORY IS SO IMPORTANT IN KENTUCKY I HAVE INCLUDED TWO SOURCES OF INFORMATION.

    PLEASE FOLLOW THE LINK TO THE VIDEO BELOW TO HEAR THE PRESS CONFERENCE WHICH WAS AIRED ON WLKY.

    THE LAWSUIT WAS FILED TODAY, JUNE 14TH, 2017, IN JEFFERSON COUNTY KENTUCKY AGAINST GOV. MATT BEVIN AND AG ANDY BESHEAR BY DANNY BELCHER OF BATH COUNTY, AMY STALKER OF JEFFERSON COUNTY, AND DAN SEUM JR OF JEFFERSON COUNTY.

    ky mj lawsuit

    ABOVE:  LINK TO PRESS CONFERENCE VIDEO ON WLKY

    FACEBOOK – WLKY PRESS CONFERENCE WITH COMMENTS

    Mark Vanderhoff Reporter

    FRANKFORT, Ky. —

    Three people are suing Kentucky Gov. Matt Bevin and Attorney General Andy Beshear over Kentucky’s marijuana laws, claiming their rights are being violated by not being able to use or possess medicinal marijuana.

    The lawsuit, filed Wednesday morning in Jefferson Circuit Court, was filed on behalf of Danny Belcher of Bath County, Amy Stalker of Louisville and Dan Seum Jr., son of state Sen. Dan Seum, R-Fairdale.

    Seum turned to marijuana after being prescribed opioid painkillers to manage back pain.

    “I don’t want to go through what I went through coming off that Oxycontin and I can’t function on it,” he said. “If I consume cannabis, I can at least function and have a little quality of life.”

    The plaintiffs spoke at a press conference Wednesday afternoon.

    Seum does not believe the state can legally justify outlawing medical marijuana while at the same time allowing doctors to prescribe powerful and highly addictive opioids, which have created a statewide and national epidemic of abuse.

    That legal justification lies at the heart of the plaintiffs’ legal challenge, which claims Kentucky is violating its own constitution.

    The lawsuit claims the prohibition violates section two of the Kentucky Constitution, which denies “arbitrary power,” and claims the courts have interpreted that to mean a law can’t be unreasonable.

    “It’s difficult to make a comparison between medical cannabis and opioids that are routine prescribed to people all over the commonwealth, all over the country, and say that there’s some sort of rational basis for the prohibition on cannabis as medicine when we know how well it works,” said Dan Canon, who along with attorney Candace Curtis is representing the plaintiffs.

    The lawsuit also claims Kentucky’s law violates the plaintiffs’ right to privacy, also guaranteed under the state constitution.

    Spokespeople for Gov. Bevin and Beshear say their offices are in the process of reviewing the lawsuit.

    In a February interview on NewsRadio 840 WHAS, Bevin said the following in response to a question about whether he supports medical marijuana:

    “The devil’s in the details. I am not opposed to the idea medical marijuana, if prescribed like other drugs, if administered in the same way we would other pharmaceutical drugs. I think it would be appropriate in many respects. It has absolute medicinal value. Again, it’s a function of its making its way to me. I don’t do that executively. It would have to be a bill.”  CONTINUE READING…

    Lawsuit challenges Kentucky’s medical marijuana ban

    By Bruce Schreiner | AP June 14 at 6:38 PM

    LOUISVILLE, Ky. — Kentucky’s criminal ban against medical marijuana was challenged Wednesday in a lawsuit touting cannabis as a viable alternative to ease addiction woes from opioid painkillers.

    The plaintiffs have used medical marijuana to ease health problems, the suit said. The three plaintiffs include Dan Seum Jr., the son of a longtime Republican state senator.

    Another plaintiff, Amy Stalker, was prescribed medical marijuana while living in Colorado and Washington state to help treat symptoms from irritable bowel syndrome and bipolar disorder. She has struggled to maintain her health since moving back to Kentucky to be with her ailing mother.

    “She comes back to her home state and she’s treated as a criminal for this same conduct,” said plaintiffs’ attorney Daniel Canon. “That’s absurd, it’s irrational and it’s unconstitutional.”

    Stalker, meeting with reporters, said: “I just want to be able to talk to my doctors the same way I’m able to talk to doctors in other states, and have my medical needs heard.” CONTINUE READING…

    Advertisements
     
  • ShereeKrider 11:19 pm on June 14, 2017 Permalink | Reply
    Tags: , Cancer, , FECO, , , Phoenix Tears Foundation, Rick Simpson, Run from the cure, Tim Allen   

    Shannon Dugas of “The Couch” Radio Show interviews Tim Simpson, member of Phoenix Tears 


    rs

    Above is a link to the full official version of the Documentary “RUN FROM THE CURE”, released January 28, 2008.

    On June 11th, Shannon Dugas, Host of “The Couch” Radio Show, interviewed Tim Simpson, long time neighbor, advocate and friend of Rick Simpson.

    It is a very interesting and informative show and I urge everyone to take the time to listen to it. 

    This week we are truly humbled to have Tim Allen from Phoenixtears. He has some very important information that he wants to share with all of us.

    HERE IS A DIRECT LINK TO AUDIO OF SHOW USING IE

    Image may contain: 2 people, people smiling, people standing

    Above:  Shannon Dugas and Co-Host Erica

    Image may contain: 1 person, sitting

    Above:  Tim Allen

    No automatic alt text available.

    14455707_1790354534581867_1171295903_o

    http://phoenixtears.ca/

    https://epsilon.shoutca.st:2197/ondemand/dcn/Replay%20The%20Couch%20June%2011%202017.mp3

    https://business.facebook.com/dunet.ca/?business_id=466135496872213&ref=page_internal

    https://www.facebook.com/tim.allen.1675

    https://www.facebook.com/ricksimpsonofficial

    http://phoenixtears.ca/rso/video-library/

    https://www.youtube.com/user/RickSimpsonOilCure/videos

    https://business.facebook.com/dunet.ca/?business_id=466135496872213&ref=page_internal

    http://www.dunet.ca/thecouch.html

    https://www.youtube.com/watch?v=zDJX7GqsQoA

     
  • ShereeKrider 12:16 am on June 14, 2017 Permalink | Reply
    Tags: Analogues, , , , HR 2851, , , , S. 1327, Schedule A, Sen. Chuck Grassley, Sen. Dianne Feinstein, SITSA ACT   

    SITSA creates a new “Schedule A” that gives the Attorney General of the United States the power to ban any “analogue” of an opioid that controls pain or provides an increase of energy. 


    Image may contain: 1 person, plant, nature and outdoor

    Kratom Advocates:

    If you’ve had one of those days that starts with friends calling you with bad news, and the news just gets worse and worse as the day goes on – then that describes my day perfectly.

    On Friday of last week, Sen. Chuck Grassley of Iowa, and Sen. Dianne Feinstein of California, dropped a bill in the U.S. Senate that our lobbyists believe will give the FDA and DEA a backdoor way of banning kratom completely in the United States.

    S. 1327 is euphemistically called the SITSA Act.  And a companion bill in the US House of Representatives has already been filed, H.R. 2851, by Representative John Katco of New York.

    The SITSA Act stands for the “Stop Importation and Trafficking of Synthetic Analogues Act of 2017.”
    SITSA creates a new “Schedule A” that gives the Attorney General of the United States the power to ban any “analogue” of an opioid that controls pain or provides an increase of energy.

    That is kratom. Because kratom’s 2 primary alkaloids, mitragynine and 7-hydroxymitragynine, though not opioids, act similarly in some ways.
    They could of just called this bill the “Schedule Kratom” Act.

    This legislation will allow the Attorney General, and his supporters at the DEA, to add kratom to Schedule A on a “temporary basis” that will last for 5 years.
    And once added to Schedule A, the Attorney General can convert it to a permanent schedule.
    After everything that we’ve fought successfully against and endured together as a movement, our lobbyists are concerned that this is now the perfect storm for banning kratom.

    Under the current Controlled Substances Act, the FDA and DEA have to prove conclusively that kratom is dangerously addictive and unsafe for consumer use. That’s why we were able to stop them in their tracks when they tried to ram through an “emergency scheduling” ban on kratom.

    And it is why the FDA is having such a tough time in finding some justification to schedule kratom under regular rulemaking.

    So now the anti-kratom bureaucrats in Washington want to ban kratom simply by claiming it has the same effects as an opioid – calling it an “analogue” of the opioid.

    And the SITSA Act can enforce a ban on kratom by criminalizing any manufacturer or distributor of kratom. Ten years imprisonment just for manufacturing or selling a kratom product, and a fine of $500,000 if you are an individual, $2,500,000 if the defendant is a company.

    If you import or export kratom, it is a 20-year sentence.

    And then there are harsh penalties for what they call “false labeling” of a Schedule A substance.
    That’s why am writing – because I need your help again.

    We have to convince Sen. Grassley, Sen. Feinstein, and Representative Katko that they have to exempt natural botanical plants from the SITSA Act.
    We have to act quickly, because I learned today that the House Judiciary Committee is looking to schedule a Hearing before they leave for recess next month.

    So I hope you will help by doing three specific things:

    1.    Click on the link below and sign our petition that the AKA will have delivered to every member of the Senate and House Judiciary Committees. 

    PLEASE SIGN THIS PETITION URGING LAWMAKERS TO REMOVE KRATOM FROM THE SITSA ACT.

    2.    I need you to pick up the phone and call Sen. Grassley’s office, Sen. Feinstein’s office, and Representative Katco’s office. When the staff member answers the phone, tell them that their boss should exclude natural botanicals like kratom products from the SITSA Act.

    Here are the phone numbers you should call:

    Senator Grassley:    (202) 224-3744
    Senator Feinstein:    (202) 224-3841
    Congressman Katco:    (202) 225-3701

    When you call, be polite, but firm.  Kratom should be exempted from SITSA.

    3.    Please click on the donation link below and help us once again to take on this fight with a team of lawyers, lobbyists, and public relations professionals.  Please consider making a monthly contribution to the AKA.

    DONATION LINK TO HELP THE AKA FIGHT THIS LEGISLATION.

    I know I am asking a lot.

    But we need to fight back hard, or they will steal our freedoms from us to make our own decisions about our health and well-being.

    So please, sign the petition, call the the sponsors of SITSA, and please, please, give as generous a contribution as you can to help us put our team on the ground in Washington, D.C.

    With your help, we have established ourselves as a real force in Washington.

    With your continued help – help that I am so grateful for – we can win this battle against the enemies of kratom.

    Your contribution will help us hire the lawyers we need for a brief on why this legislation violates due process and current law; our lobbyists to knock on doors on Capitol Hill; and our public relations team to rally the press to tell our story.

    We will stand up for freedom.

    Thank you for your continued support.

    Sincerely,

    Susan Ash
    Founder and Spokesperson
    American Kratom Association
    http://www.americankratom.org

    http://mailchi.mp/americankratom/new-legislative-attack-on-kratom?e=2709219685

    https://www.facebook.com/kratom.us/photos/rpp.260289027341069/873568049346494/?type=3&theater

     
  • ShereeKrider 2:50 am on May 30, 2017 Permalink | Reply
    Tags: 1937 Tax Act, , culture, Harry Anslinger, Hearst, , , Pharmaceutical Cannabis   

    The Origin of the Word ‘Marijuana’ 


    Anna Wilcox

    The word “marijuana” plays a controversial role in cannabis culture. Many well-known organizations such as Oakland’s Harborside Heath Center have publicly denounced “the M word” in favor of our favorite plant’s Latinate name, cannabis. Even Salon Magazine, a major press outlet outside of the cannabis industry, published an article titled “Is the word ‘Marijuana’ racist?” last year.

    As mainstream culture becomes a little more herb-friendly, the terminology used by the industry is coming to center stage. But, why exactly does the term “marijuana” cause so much debate? Even worse, why has the word gained publicity as a racist term?

    To save you from reading those lengthy history books or some boring academic articles, we’ve created this brief timeline to give you the low-down on “marijuana”’s rise to popularity in the United States. Here’s what you need to know:

    The Mexican Revolution

    1840-1900:

    Prior to 1910, “marijuana” didn’t exist as a word in American culture. Rather, “cannabis” was used, most often in reference to medicines and remedies for common household ailments. In the early 1900s, what have now become pharmaceutical giants—Bristol-Meyer’s Squib and Eli Lilly—used to include cannabis and cannabis extracts in their medicines.

    During this time, Americans (particularly elite Americans) were going through a hashish trend. Glamorized by literary celebrities such as Alexander Dumas, experimenting with cannabis products became a fad among those wealthy enough to afford imported goods.

    1910:

    Between the years of 1910 and 1920, over 890,000 Mexicans legally immigrated into the United States seeking refuge from the wreckage of civil war. Though cannabis had been a part of U.S. history since the country’s beginnings, the idea of smoking the plant recreationally was not as common as other forms of consumption. The idea of smoking cannabis entered mainstream American consciousness after the arrival of immigrants who brought the smoking habit with them.

    1913:

    The first bill criminalizing the cultivation of “locoweed” was passed in California. The bill was a major push from the Board of Pharmacy as a way to regulate opiates and psychoactive pharmaceuticals, and seemingly did not stem from the “reefer madness” or racialized understanding of “marijuana” that paved the way to full-on prohibition in the 1930s.

    The Aftermath

    1930s:

    The Great Depression had just hit the United States, and Americans were searching for someone to blame. Due to the influx of immigrants (particularly in the South) and the rise of suggestive jazz music, many white Americans began to treat cannabis (and, arguably, the Blacks and Mexican immigrants who consumed it) as a foreign substance used to corrupt the minds and bodies of low-class individuals.

    In the time just before the federal criminalization of the plant, 29 states independently banned the herb that came to be known as “marijuana.”

    Harry Anslinger:

    It would not be an overstatement to say that Harry Anslinger was one of the primary individuals responsible for creating the stigma surrounding cannabis. Hired as the first director of the recently created Federal Bureau of Narcotics in 1930, Anslinger launched a vigilant campaign against cannabis that would hold steady for the three decades he remained in office.

    A very outspoken man, Anslinger used the recent development of the movie theater to spread messages that racialized the plant for white audiences. In one documented incident, Anslinger testified before Congress, explaining:

    “Marijuana is the most violence-causing drug in the history of mankind… Most marijuana smokers are Negroes, Hispanics, Filipinos and entertainers. Their satanic music, jazz and swing, result from marijuana usage.”

    In another statement, Anslinger articulated: “Reefer makes darkies think they’re as good as white men…the primary reason to outlaw marijuana is its effect on the degenerate races.”

    In retrospect, Anslinger’s efforts with the Bureau of Narcotics were the reason “marijuana” became a word known by Americans all over the country. When making public appearances and crafting propaganda films such as Reefer Madness, Anslinger specifically used the term “marijuana” when campaigning against the plant, adding to the development of the herb’s new “foreign” identity.

    Cannabis was no longer the plant substance found in medicines and consumed unanimously by American’s all over the country.

    1937:

    The Marihuana Tax Act of 1937 was the culmination of Anslinger’s work and the first step to all-out prohibition. The bill federally criminalized the cannabis plant in every U.S. state. In order to discourage the production of cannabis use, the Tax Act of 1937 placed a one dollar tax on anyone who sold or cultivated the cannabis plant.

    On top of the tax itself, the bill mandated that all individuals comply with certain enforcement provisions. Violation of the provisions would result in imprisonment and/or a fine of up to $2,000.

    Though the word “marijuana” is the most common name for cannabis in the United States today, its history is deeply steeped in race, politics, and a complicated cultural revolution. Some argue that using the word ignores a history of oppression against Mexican immigrants and African Americans, while others insist that the term has now lost its prejudiced bite. Regardless of whether or not you decide to use the word yourself, it’s impossible to deny the magnitude and racial implications of its introduction to the American lexicon.

    CONTINUE READING…

     
  • ShereeKrider 6:04 pm on May 28, 2017 Permalink | Reply
    Tags: , , , LegitScript   

    AKA Responds to Kratom Businesses Being Targeted 


    aaa432d3-79ff-40e4-935e-acd01c48d905

    May 27, 2017

    FOR IMMEDIATE RELEASE

    AKA Responds to Kratom Businesses Being Targeted

    The American Kratom Association (AKA) strongly condemns the recent actions taken by LegitScript and hosting providers to shut down the Internet domains of legitimate businesses who are selling safe kratom products to consumers in the United States.

    We have received reports that a trusted Internet vendor had their domain completely shut down by GoDaddy, the web hosting company, based on the LegitScript report.

    Based on our review of the “Red Flag” alerts by LegitScript relating to kratom, it is clear they relied upon outdated and inaccurate information (a 2014 FDA Press Release, and a 2015 DEA publication) from the FDA and DEA that materially misrepresents the pharmacological properties of kratom and kratom’s addiction and safety profile.

    The DEA published a Notice of Intent for emergency scheduling of kratom as a Schedule I controlled substance on August 31, 2016. On October 13, 2016, the DEA, in an unprecedented regulatory move, withdrew its Notice of Intent, and requested the FDA provide a statutorily-mandated Eight-Factor Analysis on the addiction and safety profile of kratom justifying whether any legal basis exists to schedule kratom at all. The DEA requested the FDA response by December 1, 2016. As of this date, the FDA has not made any subsequent recommendation for the scheduling of kratom, or provided the requested Eight-Factor Analysis.

    On November 28, 2016, the AKA submitted an Eight-Factor Analysis on kratom that was conducted by one of the preeminent scientists in the field of addiction profiles and safety of dietary supplements, Dr. Jack Henningfield of Pinney Associates. This Analysis mirrors the statutorily-mandated criteria for an Eight-Factor Analysis that would be used to support a scheduling recommendation by the FDA for any product they believe should be scheduled as a controlled substance.

    Dr. Henningfield’s analysis concluded: (1) scheduling kratom as a controlled substance is not warranted from a public health perspective; (2) kratom has very low toxicity, and thus a favorable safety profile; and (3) there have been no confirmed reports of death that can be causatively due to kratom overdose.  This Analysis was submitted to the FDA and the DEA and there has been no attempt to schedule kratom in the following six months, despite the initial view that kratom required “emergency scheduling.”

    This updated research is conclusive, and we believe LegitScript should immediately rescind their action, just as the DEA did in October 2016.

    The AKA fully supports appropriate regulatory actions against any adulterated substance that poses a danger to the public health. The demonization of kratom, which appears to have originated in unjustified accusations that kratom is an “opioid” that has led to deaths of consumers. has proven to be completely false.  This outdated and inaccurate information should not be the basis for any regulatory or business decision by any organization.

    The actions taken by LegitScript directly interferes with the freedoms of consumers to make individual choices about their health and well-being, and raises significant concerns about a nongovernmental agency intervening in commerce causing significant economic harm to American businesses.  It also unjustifiably erects barriers to access to the millions of Americans who choose to use kratom as a part of their personal plan for their own health and well-being.

    The AKA will work closely with LegitScript, and appropriate regulatory agencies, to correct this egregious decision.  We will also seek the assistance of the appropriate regulatory agencies to correct the outdated and inaccurate information they have published that has served as the basis for the unwarranted decisions by LegitScript related to kratom.

    Sincerely,

    The AKA Board of Directors

    http://www.americankratom.org

     
  • ShereeKrider 4:11 am on May 11, 2017 Permalink | Reply
    Tags: H 170, Recreational Marijuana, , VT   

    Vermont lawmakers become first to approve legal pot 


    AP MARIJUANA STATES OF PLAY A FILE USA CA

    April McCullum, The Burlington (Vt.) Free Press

    MONTPELIER, Vt. — Vermont’s Legislature become the first in the nation Wednesday to approve a recreational marijuana legalization bill.

    Vermont’s bill, which would legalize small amounts of marijuana possession in 2018 and anticipate the possibility of a taxed and regulated legal marijuana market, was approved in the Vermont House of Representatives on Wednesday afternoon by a vote of 79-66. The state Senate already passed the bill, so it will go directly to GOP Gov. Phil Scott.

    Eight states — Alaska, California, Colorado, Maine, Massachusetts, Nevada, Oregon and Washington — and the District of Columbia have legalized marijuana following a voter referendum, but no state yet has legalized marijuana solely through the legislative process, according to the National Conference of State Legislatures. Legalization advocates said bills were pending in other state legislatures.

    “I think it reflects that Vermont elected officials are more in touch with our constituents than a lot of elected officials in other states,” said Vermont Lt. Gov. David Zuckerman, a member of the Vermont Progressive Party who has worked on marijuana issues for the majority of his political career. “I think the public is ahead of us, but elected officials tend to be cautious when it comes to change.”

    Wednesday’s vote closed a debate over legalization, particularly in the state House. The divisiveness once prompted Senate President Pro Tempore Tim Ashe, a Democrat from Burlington, Vt., to predict that legalization would take a miracle to pass this year.

    Advocates hugged and shared high-fives outside the two chambers after the vote.

    “Vermont elected officials are more in touch with our constituents than a lot of elected officials in other states.”

    Earlier in the day, the House Judiciary Committee voted 8-3 to support the limited bill, which was pitched as a compromise between the House and Senate approaches on marijuana.

    The proposal incorporates H.170, a House-supported bill that would legalize possession of up to one ounce of marijuana, two mature marijuana plants or four immature marijuana plants for adults older than 21. The effective date was pushed to July 1, 2018.

    The bill also sets up a nine-member commission to study the best way to regulate marijuana.

    “There’s no slam dunk of any kind,” Rep. Barbara Rachelson, a Burlington Democrat, said about the prospect of a legal marijuana market. “It just is doing work that could be used next year or in subsequent years.”

    The proposal would continue to prohibit driving under the influence of marijuana and the use of marijuana in public places. Employers, landlords, schools and prisons could continue to restrict marijuana use.

    “The data indicates that our youth are using marijuana more infrequently, and I don’t think we should put that in jeopardy,” said GOP Rep. Scott Beck of St. Johnsbury, Vt., who voted against the bill.

    Democratic Rep. Susan Buckholz of Hartford, Vt., said declining marijuana use among the state’s high school students, measured at 37% in the latest Vermont Youth Risk Behavior Survey, shows that anti-drug education is working.

    “We need to make a move to be treating this as a public health issue for those for whom it is a health issue and letting other people use this substance responsibly,” Buckholz said.

    Vermont's House minority leader, GOP Rep. Don Turner

    Vermont’s House minority leader, GOP Rep. Don Turner of Milton, speaks May 10, 2017, against a marijuana legalization bill at the Statehouse in Montpelier, Vt. (Photo: Glenn Russell, The Burlington (Vt.) Free Press)

    If Scott signs the bill, a new commission would be responsible for drafting a system to tax and regulate marijuana and submitting the plan to the Legislature. The end result would need to be a marijuana regulatory system that  “increases public safety and reduces harm to public health.”

    “The administration will be at the table, along with the attorney general and others,” said Democratic Rep. Maxine Grad of Moretown, Vt., chairwoman of the House Judiciary Committee. “With Massachusetts and Maine starting up in 2018, I think we need to continue this conversation.”

    Scott repeatedly has expressed concerns about marijuana and highway safety. He has the choice to sign the bill, veto the bill, or allow it to become law without his signature.

    The first-term Republican governor declined to say before Wednesday’s House vote whether he would veto the legislation.

    “I don’t believe this is a priority for Vermont,” Scott said. “I believe that what we should be doing is trying to find ways to protect those on our highways, deliver a level of impairment that is consistent throughout the Northeast, as well as to address the edibles for our kids before we move forward with legalization. Having said that, I’m going to review the bill as it’s passed.”

    Follow April McCullum on Twitter: @April_McCullum

    Note: Vermont legislators changed the effective date of the bill below to July 1, 2018.

    CONTINUE READING….

    PDF OF H 170 AND VIDEO

     
  • ShereeKrider 1:46 am on April 14, 2017 Permalink | Reply
    Tags: , Canadian Cannabis Act, , , , medical, personal use,   

    Canada takes action to legalize and strictly regulate cannabis 


    News Release

    From Health Canada

    Proposed legislation would provide regulated and restricted access to cannabis and crack down on impaired driving

    April 13, 2017              Ottawa, ON      

                                                               Government of Canada

    The current approach to cannabis does not work. It has allowed criminals and organized crime to profit, while failing to keep cannabis out of the hands of Canadian youth. In many cases, it is easier for our kids to buy cannabis than cigarettes.

    That is why the Government of Canada, after extensive consultation with law enforcement, health and safety experts, and the hard work of the Task Force on Cannabis Legalization and Regulation, today introduced legislation to legalize, strictly regulate and restrict access to cannabis.

    The proposed Cannabis Act would create a strict legal framework for controlling the production, distribution, sale and possession of cannabis in Canada. Following Royal Assent, the proposed legislation would allow adults to legally possess and use cannabis. This would mean that possession of small amounts of cannabis would no longer be a criminal offence and would prevent profits from going into the pockets of criminal organizations and street gangs. The Bill would also, for the first time, make it a specific criminal offence to sell cannabis to a minor and create significant penalties for those who engage young Canadians in cannabis-related offences.   

    In addition to legalizing and strictly regulating cannabis, the Government is toughening laws around alcohol- and drug-impaired driving. Under the Government’s proposed legislation, new offences would be added to the Criminal Code to enforce a zero tolerance approach for those driving under the influence of cannabis and other drugs. Additionally, the proposed legislation would authorize new tools for police to better detect drivers who have drugs in their body.

    Subject to Parliamentary approval and Royal Assent, the Government of Canada intends to provide regulated and restricted access to cannabis no later than July 2018.

    The Government will invest additional resources to make sure there is appropriate capacity within Health Canada, the Royal Canadian Mounted Police, the Canada Border Services Agency and the Department of Public Safety to license, inspect and enforce all aspects of the proposed legislation. These additional resources will also allow the Government to undertake a robust public awareness campaign so that Canadians are well informed about the dangers of driving under the influence of cannabis and other drugs.

    Working in partnership with provinces, territories, municipalities and local communities, the Government will also make appropriate investments to train and equip law enforcement so that Canada’s roads and highways are safe for all Canadians.

    In the months ahead, the Government will share more details on a new licensing fee and excise tax system. It will also continue to engage with all levels of government and Indigenous Peoples.

    Quotes

    “As a former police officer, I know firsthand how easy it is for our kids to buy cannabis. In many cases, it is easier for our children to get cannabis than it is to get cigarettes. Today’s plan to legalize, strictly regulate and restrict access to cannabis will put an end to this. It will keep cannabis out of the hands of children and youth, and stop criminals from profiting from it.”
    Bill Blair
    Parliamentary Secretary to the Minister of Justice

    “Today, we are following through on our commitment to introduce comprehensive legislation to legalize, strictly regulate and restrict access to cannabis and to create new laws to punish more severely those who drive under its influence. The Cannabis Act reflects an evidence-based approach that will protect Canadians’ public health and safety. By tackling alcohol- and drug-impaired driving with new and tougher criminal offences, Canadians will be better protected from impaired drivers and the number of deaths and accidents on our roads will be reduced.”
    The Honourable Jody Wilson-Raybould
    Minister of Justice and Attorney General of Canada

    “The bills we propose today are aiming at putting drug dealers and organized crime out of the cannabis business. It will allow law enforcement to focus on other serious offences, including the distribution of cannabis to children and youth and driving under the influence of drugs. Drug-impaired driving puts the lives and the safety of drivers and passengers at risk every day, and we will lead a wide-ranging campaign to raise awareness of the dangers of driving while impaired. The proposed Bill will also provide more tools and stronger laws to punish more severely drivers who drive under the influence of drugs, including cannabis. We will continue to work with our law enforcement, provincial and territorial partners and stakeholders to develop a consistent enforcement approach and to provide support in building capacity across the country.”
    The Honourable Ralph Goodale
    Minister of Public Safety and Emergency Preparedness

    “The Cannabis Act will help keep our children safe and address the health risks associated with cannabis. The proposed legislation would allow Canadian adults to possess and purchase regulated and quality-controlled cannabis products, while prohibiting sales to young Canadians and any products, promotion, packaging or labelling that could be appealing to young people.”
    The Honourable Jane Philpott
    Minister of Health

    Quick Facts

    • The Cannabis Act proposes that legal sales of cannabis would be restricted to people who are 18 years of age and over. Provinces and territories could increase the minimum legal age of sale, purchase and consumption.
    • The movement of cannabis and cannabis products across international borders would remain a serious criminal offence.
    • Following Royal Assent, the Government intends to bring the proposed Act into force no later than July 2018. At that time, adults would legally be able to possess up to 30 grams of legal cannabis in public, and to grow up to four plants per household at a maximum height of one metre from a legal seed or seedling. Until the new law comes into force, cannabis will remain illegal everywhere in Canada, except for medical purposes.
    • The provinces and territories would authorize and oversee the distribution and sale of cannabis, subject to minimum federal conditions. In those jurisdictions that have not put in place a regulated retail framework, individuals would be able to purchase cannabis online from a federally licensed producer with secure home delivery through the mail or by courier.
    • The proposed legislation would amend the Criminal Code to modernize and simplify the transportation provisions, strengthen the criminal law responses to impaired driving, and facilitate the effective and efficient investigation and prosecution of drug- and alcohol-impaired driving.
    • To facilitate detection and investigation of drug-impaired driving, law enforcement officers will be authorized and equipped to use oral fluid drug screeners at the roadside.

    Related Products

    – 30 –

    Contacts

    David Taylor
    Office of the Minister of Justice
    613-992-4621

    Media Relations
    Department of Justice Canada
    613-957-4207
    media@justice.gc.ca

    Andrew MacKendrick
    Office of the Minister of Health
    613-957-0200

    Media Relations
    Health Canada
    613-957-2983

    Scott Bardsley
    Office of the Minister of Public Safety and Emergency Preparedness
    613-998-5681

    Media Relations
    Public Safety Canada
    613-991-0657
    media@ps-sp.gc.ca

    Public Inquiries:
    613-957-2991
    1-866 225-0709

    SOURCE LINK

     
  • ShereeKrider 1:48 am on February 8, 2017 Permalink | Reply
    Tags: brain cancer, Cannabidiol, Cannabis Therapy, Epidolex, Glioblastoma multiforme, GW Pharmaceuticals   

    The Next Big Brain Cancer Drug Could Come from Marijuana 


    Sy Mukherjee

    9:44 PM Central

    Image result for marijuana

    GW Pharmaceuticals (gwph, +2.63%) is already well on its way to winning the first-ever U.S. approval for a cannabis-derived therapy. But an early trial suggests that these treatments could also be an effective way to fight one of most devastating forms of brain cancers: glioblastoma multiforme.

    The U.K.-based company unveiled preliminary data Tuesday from a mid-stage study on an experimental drug combining cannabidiol and THC, the “high” producing element of marijuana. Results so far show that the drug boosted brain cancer patients’ median survival rates by about six months compared to a placebo. Typically, this type of cancer ravages the brain and (on average) leaves 70% of patients dead within two years of being diagnosed.

    Click here to subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

    “We believe that the signals of efficacy demonstrated in this study further reinforce the potential role of cannabinoids in the field of oncology and provide GW with the prospect of a new and distinct cannabinoid product candidate in the treatment of glioma,” GW CEO Justin Gover said in a statement.

    GW is already interpreting the results as a reason to expand its foray into cancer treatment. The company’s most advanced drug candidate, Epidiolex (for treatment of severe epilepsy related to a number of rare disorders), is closest to reaching the U.S. market. But the firm has staked out more far-reaching ambitions in an environment where cannabis-based products have been increasingly accepted.

    For one, Gover thinks that cannabidiol-based therapies show plenty of promise in behavioral disorders like schizophrenia, he told Fortune last year.

    Marijuana’s effect on cancer still isn’t all that clear. A big recent review by American scientists suggests the drug is effective for treating pain and nausea in cancer patients but doesn’t necessarily treat (or cause) cancer. However, GW’s drug isn’t just a bowl of weed to be smoked – it contains concentrated derivatives and is undergoing the kind of clinical testing that could provide insights hampered by U.S. policy towards studying cannabis.

    CONTINUE READING…

    http://fortune.com/2016/09/26/gw-pharmaceuticals-marijuana-therapy/

     
  • ShereeKrider 10:09 pm on December 30, 2016 Permalink | Reply  

    The Reintroduction of Psychedelic Drugs Into Society. — News Leak 


    For thousands of years, human beings have sought after and experienced altered states of consciousness. Meditation, sleep deprivation, fasting and the use of psychedelic substances have all been used in order to alter the mind and body’s regular functions and bring about these altered states. Until fairly recently, the physiological changes in the body underlying these effects, especially in regards to psychedelic substances, were largely unknown due to a significant lack of thorough research into them.

    via The Reintroduction of Psychedelic Drugs Into Society. — News Leak

     
  • ShereeKrider 5:24 pm on December 19, 2016 Permalink | Reply
    Tags: , ,   

    Ananda Hemp Comments on Recent DEA Ruling 


    News provided by

    Ananda Hemp

    Dec 19, 2016, 11:26 ET

     

    LEXINGTON, Ky., Dec. 19, 2016 /PRNewswire/ — Last Wednesday, December 14th, the Drug Enforcement Administration (DEA) issued a ruling on the coding of “marihuana extracts.” Many questions have arisen in the marketplace from those concerned that the intention of the agency was to seemingly classify hemp-derived extracts containing Cannabidiol (CBD) Schedule I substances.

    Ananda Hemp and our parent company Ecofibre have sought legal advice and believe the Final Rule published by DEA doesnot change the legal status of CBD as this can only be done by a scheduling action which has NOT occurred. We are within the belief that the ruling was a mere administrative action and not an attempt to bypass any Congressionally imposed laws such as the 2014 Farm Bill, or any other necessary judicial process.

    We strongly believe that our farming operations and products obtained under those operations are, and will continue to be, compliant and legal in all 50 states:

    • Cannabidiol (CBD) is not listed on the federal schedule of controlled substances;
    • Sec. 7606 of the Farm Bill defines hemp as distinct from marijuana and is therefore removed from the definition as a controlled substance when grown under a compliant state program;
    • The 2015 Congressional Appropriations act and corresponding 2016 Appropriations Act specifically defunded the DEA and other governmental agencies from interfering with the processing, use, or sale of industrial hemp that was cultivated in compliance with section 7606 of the 2014 Farm Bill;
    • The code assigned to “marihuana extract” in the rule is “Administration Controlled Substances Code Number” for the purposes of identification of substances on registration forms;
    • Therefore, the Final Rule published on December 14th was not a scheduling action but rather an administrative action related to record keeping

    Ecofibre has been working in the state of Kentucky since 2014 and operated under the full extent of section 7606 of the 2014 Farm Bill. To date the company has invested millions of dollars in the region and created a broad range of jobs and farming salaries in Central Kentucky. This year we contracted 500 acres of industrial hemp production and have recently completed yet another successful harvest season. Our brand, Ananda Hemp, has recently entered the marketplace in good favor with consumers and channel partners as we now endeavor to enter into the market research phase of our 5-year pilot program.

    Our company will continue to scale our operations in Kentucky and the USA alike by continuing to contract industrial hemp production with American farmers and bringing quality, domestically-produced products to market for sale in all 50 states.

    About Ecofibre

    Ecofibre is an Australian company that maintains one the world’s largest and most diverse seed banks of cannabis sativa germplasm, which includes several certified industrial hemp cultivars.

    Ecofibre has strong research partnerships with several leading Universities and currently utilizes its licenses to grow industrial hemp for the purposes of research and production.

    Ecofibre is privately funded by some of Australia’s leading business leaders as well as Joy and Barry Lambert, the most noted cannabis philanthropists in the industry.

    Contact
    Eric Wang
    +61 (0)403 570 377 
    eric.wang@ecofibre.com.au

    About Ananda Hemp

    Ananda Hemp is a premier provider of health and wellness products that are exclusively derived from industrial hemp cultivated compliantly in Kentucky, USA under the accordance of section 7606 of the 2014 Farm Bill.

    Contact
    John Ryan
    +1 858 405 8615
    john@anandahemp.com

    SOURCE Ananda Hemp

     
c
Compose new post
j
Next post/Next comment
k
Previous post/Previous comment
r
Reply
e
Edit
o
Show/Hide comments
t
Go to top
l
Go to login
h
Show/Hide help
shift + esc
Cancel
%d bloggers like this: